ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,816Medicare Part D Prescriptions Filled, Including Refills

Rank: 314 out of 2588

$819K Total Retail Price of All Prescriptions

Rank: 148 out of 2588

469 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

12% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,365 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 382 360 1 1
LISINOPRIL 380 332 2 3
AMLODIPINE BESYLATE 369 356 3 4
HYDROCODONE-ACETAMINOPHEN 343 273 S3 4 7
LEVOTHYROXINE SODIUM 307 288 5 2
OMEPRAZOLE 286 258 6 6
DONEPEZIL HCL 263 263 7 22
ATORVASTATIN CALCIUM 251 228 8 11
METOPROLOL TARTRATE 249 210 9 9
FUROSEMIDE 243 215 10 5
WARFARIN SODIUM 240 221 11 10
ZOLPIDEM TARTRATE 172 166 12 24
HYDROCHLOROTHIAZIDE 171 159 13 13
NAMENDA 165 165 14 32
METOPROLOL SUCCINATE 159 156 15 12
CLOPIDOGREL 151 136 16 30
METFORMIN HCL 149 138 17 8
PLAVIX 129 121 18 43
GABAPENTIN 120 102 19 18
TRAMADOL HCL 108 97 20 19
ADVAIR DISKUS 107 107 21 48
CITALOPRAM HBR 105 83 22 27
QUETIAPINE FUMARATE 100 84 23 74
CARVEDILOL 98 81 24 20
SERTRALINE HCL 91 84 25 26
HYDROMORPHONE HCL 90 0 S2 26 291
LOSARTAN POTASSIUM 85 85 27 17
POTASSIUM CHLORIDE 83 76 28 15
DIOVAN 83 83 28 29
PREDNISONE 80 66 30 42
LOSARTAN-HYDROCHLOROTHIAZIDE 79 79 31 66
ALLOPURINOL 79 70 31 33
LEVETIRACETAM 78 56 33 90
ALENDRONATE SODIUM 76 76 34 21
ATENOLOL 75 75 35 14
SYNTHROID 71 58 36 88
GLIMEPIRIDE 71 57 36 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 65 38 35
LANTUS SOLOSTAR 67 49 39 93
MIRTAZAPINE 66 59 40 63
POLYETHYLENE GLYCOL 3350 63 52 41 55
MELOXICAM 62 50 42 51
PAROXETINE HCL 62 61 42 71
OXYBUTYNIN CHLORIDE ER 61 60 44 85
PEN NEEDLE 61 48 44 112
PRAVASTATIN SODIUM 61 52 44 16
VENLAFAXINE HCL ER 60 60 47 125
FAMOTIDINE 60 44 47 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 54 49 127
OXYCODONE HCL 58 15 S2 49 259
RISPERIDONE 57 52 51 57
SPIRIVA 57 54 51 56
LANTUS 56 28 53 47
DIGOXIN 55 47 54 38
CYMBALTA 53 48 55 70
DIOVAN HCT 51 51 56 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.